Genscript Biotech Corporation enterprise value

The Enterprise Value as of November 2026 (TTM) for Genscript Biotech Corporation (GNNSF) is 9.78B

According to Genscript Biotech Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 9.78B. This represents a change of 204.89% compared to the average of 3.21B of the last 4 quarters.

Genscript Biotech Corporation (GNNSF) Historical Enterprise Value (quarterly & annually)

How has GNNSF Enterprise Value performed in the past?

The mean historical Enterprise Value of Genscript Biotech Corporation over the last ten years is 3.82B. The current 9.78B Enterprise Value has changed 156.19% with respect to the historical average. Over the past ten years (40 quarters), GNNSF's Enterprise Value was at its highest in in the December 2021 quarter at 8.20B. The Enterprise Value was at its lowest in in the June 2013 quarter at 0.

Genscript Biotech Corporation (GNNSF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genscript Biotech Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genscript Biotech Corporation (GNNSF) Average Enterprise Value

How has GNNSF Enterprise Value performed in the past?

The current Enterprise Value of Genscript Biotech Corporation (GNNSF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Genscript Biotech Corporation (GNNSF) Enterprise Value vs. Peers

How is GNNSF’s Enterprise Value compared to its peers?

Genscript Biotech Corporation’s Enterprise Value is less than WuXi Biologics (Cayman) Inc. (163.04B), less than Medtide Inc. (0), greater than Viva Biotech Holdings (2.13B), less than Lonza Group AG (49.89B), less than Charles River Laboratories International, Inc. (18.37B), less than Joinn Laboratories(China)Co.,Ltd. (31.55B), less than Sartorius Stedim Biotech S.A. (23.89B), less than Samsung Biologics Co.,Ltd. (73.90T), less than Bio-Techne Corporation (11.45B), less than Bio-Rad Laboratories, Inc. (10.85B),

Build a custom stock screener for Genscript Biotech Corporation (GNNSF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genscript Biotech Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genscript Biotech Corporation (GNNSF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genscript Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.